Salbulin MDPI Novolizer is a type of inhalation medication designed for the management and treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It contains the active ingredient salbutamol, which is a short-acting β2-adrenergic receptor agonist. This medication works by relaxing the muscles in the airways, thereby opening the bronchial tubes and making it easier for the patient to breathe. The Novolizer device is a multi-dose powder inhaler (MDPI) that delivers a specific dose of the medication directly to the lungs. It is designed for ease of use and to ensure that the medication is administered effectively. Patients are advised to use Salbulin MDPI Novolizer under the guidance of a healthcare professional to manage their symptoms effectively.